BAKER STEPHEN RICHARD,BEADLE CHRISTOPHER DAVID,CLARK BARRY PETER,MONN JAMES ALLEN,PRIETO LOURDES
申请号:
NZ62645613
公开号:
NZ626456A
申请日:
2013.01.29
申请国别(地区):
NZ
年份:
2016
代理人:
摘要:
The present disclosure provides novel mGlu2/3 agonists of formula (I) useful in the treatment of neurological or psychiatric disorders. An example of the compound is (1S,2S,5R,6S)-2-[[(2S)-2-amino-4-methylsulfanyl-butanoyl]amino]spiro[bicyclo[3.1.0]hexane-4,1’-cyclopropane]-2,6-dicarboxylic acid.